Injective’s INJ heads toward Wall Street with proposed INJC staking ETF
Canary Capital's amended filing for a staked INJ fund joins at least three pending applications as Injective's CEO argues a 2027 timeline is too cautious
Injective’s native token, INJ, may soon have a ticker that looks right at home in a standard brokerage account: INJC.
Canary Capital is behind the proposed Staked INJ ETF. It submitted an amended registration statement to the SEC on September 24, 2026. The product would offer INJ exposure without a crypto wallet, and it plans to stake most of its holdings for extra yield.
Injective is a Layer 1 blockchain built for finance and tokenization. It now finds itself in a growing pile of ETF paperwork, and its CEO thinks regulators may move faster than the market expects.
What INJC actually is
INJC would hold INJ tokens directly, giving investors spot exposure to the asset’s price. On top of that, the fund’s structure targets staking approximately 90% of its holdings.
Staking means locking tokens up to help secure a blockchain network. In return, the network pays rewards.
BitGo is set to serve as custodian, meaning it would hold the fund’s tokens. The fund is planned for listing on Cboe BZX.
An S-1 is the registration document a company or fund files with the SEC before offering securities to the public. Amendments usually follow feedback or updates, so a revised filing suggests the process is still moving rather than stalled.
A crowded line at the SEC
Canary is not alone. At least three INJ-related ETF applications are currently pending with the SEC.
The news moving money, markets, and the world—before your day starts.
Daily. Free. Join 34,000+ readers across crypto, finance, and policy.
Alongside Canary’s INJC, proposals from 21Shares and REX-Osprey are also in the queue.
Injective CEO Eric Chen has suggested that the timing could come sooner than some expect. In an interview on October 5, 2026, he indicated that a 2027 launch for US INJ-linked ETFs seems overly cautious. With multiple active applications in motion, Chen suggested US INJ ETFs could launch before 2027.
Meanwhile, back in the ecosystem
In early October 2026, the Injective Foundation launched the Trench Treasury program. Its goal is to fund smaller projects building on Injective and reward people who contribute to the community.
The first round of funding is aimed at initiatives including Sprout and RunUp.
The bigger picture for staked crypto ETFs
Staking inside an ETF adds a yield component, which makes it look a bit more like an income investment and a bit less like a pure price bet.
Staked tokens can be harder to move quickly, so a fund that stakes most of its holdings has to manage redemptions carefully. Keeping a slice unstaked is one way to handle that.
What this means
If approved, INJC could open the token to investors who would never set up a crypto exchange account. Three separate INJ applications suggest issuers see demand.
Regulatory timelines can slip, and Chen’s pre-2027 view remains a projection, not a decision. Staking also carries its own technical and liquidity considerations that a traditional ETF investor may not be used to thinking about.
What to watch next: further amendments to Canary’s S-1, any movement on the 21Shares and REX-Osprey proposals, and whether the SEC signals comfort with staking inside an exchange-traded wrapper. On the ecosystem side, how Sprout, RunUp and other Trench Treasury recipients develop will show whether Injective’s on-chain activity can keep pace with its Wall Street ambitions.